Recombinant activated factor VII for acute intracerebral hemorrhage.
about
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaRecombinant activated Factor VII for prevention and treatment of intraventricular haemorrhage in neonatesRecombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaHaemostatic drug therapies for acute spontaneous intracerebral haemorrhageRecombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophiliaHaemostatic drug therapies for acute primary intracerebral haemorrhageVenous thromboembolic diseaseManagement of intraventricular hemorrhageRecently published papers: out with the old and in with the new ... then something new for the old!Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleedingAggressive Blood Pressure Lowing Therapy in Patients with Acute Intracerebral Hemorrhage is Safe: A Systematic Review and Meta-analysisRational Use of Recombinant Factor VIIa in Clinical PracticeIntracerebral Hemorrhage: Perihemorrhagic Edema and Secondary Hematoma Expansion: From Bench Work to Ongoing ControversiesTargeting Secondary Hematoma Expansion in Spontaneous Intracerebral Hemorrhage - State of the ArtWhat's new in stroke prevention and treatmentTreating the acute stroke patient as an emergency: current practices and future opportunities.Coagulation abnormalities in critically ill patientsIntracerebral haemorrhage: an often neglected medical emergencyResearch and technology in neurocritical care.The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.Chronic hydrocephalus and perihematomal tissue injury developed in a rat model of intracerebral hemorrhage with ventricular extension.Where will the next generation of stroke treatments come from?Misdiagnosis of stroke.Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding.Thalamic haemorrhage vs internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality.Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.Aptamers: the emerging class of future anticoagulation for vascular disease.Intracerebral haemorrhagePATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial.Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhageEmergency neurological care of strokes and bleeds.Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomesPreclinical Studies and Translational Applications of Intracerebral Hemorrhage.Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indicationsSmall intracerebral haemorrhages are associated with less haematoma expansion and better outcomes.The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?Recombinant activated factor VII in controlling bleeding in non-hemophiliac patientsPredicting hematoma expansion after primary intracerebral hemorrhageEndoscopic minimally invasive neurosurgery: emerging techniques and expanding role through an extensive review of the literature and our own experience - part I: intraendoscopic neurosurgery.The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors.
P2860
Q24201292-3E8288D7-DB5A-4AA0-9B0A-043FF10AE3E8Q24236446-6CBC22F4-D3C8-40C5-832A-9D99BF63DDE5Q24236583-4A110E2B-01FB-4EC2-85F8-B824E9FF5847Q24240451-ED899A27-1F20-4F73-8C5A-719C53FB2BE5Q24245204-8E720DA0-36C6-4341-B799-6748AF703EB6Q24245531-DD61DF45-41CF-4DB4-8DEA-4A378B06E68FQ24631121-40FFF24A-C1EA-4F69-A162-0A16C9B5C4D4Q24632452-C7500DAE-1193-4954-8EC3-BEF53DE23F1EQ24811894-79B99EF7-42F2-48C3-9047-5D1E81357644Q25256556-42C76086-6FEB-43A5-916B-78FD1623C470Q26781200-3CBDE349-8B68-4C5C-9AF7-AA607E37D854Q26829915-4A281CD4-72C8-467C-BAC2-8180213EB783Q28073307-6EB02C60-4AC8-40A5-9B78-36BEE481AA88Q28075902-57D620CC-B87D-4525-B29B-022DB4F9BD36Q28194923-84693A8D-A8F1-4986-B961-E0A6B6E7A0DEQ28196628-CEE0F53B-44C4-4DE9-AB8F-A9DA62D6AB62Q28199912-FA48039E-A413-4DCC-8DF2-1368882488A2Q28212587-28D6696F-82CD-4B50-9183-D327E6DD66BEQ30416859-5E3D36F7-57C9-4CCB-B09F-F36F7F0ADA1FQ30833127-2304574C-3305-45BB-A7C1-A7B3EA1E1EEFQ30845936-DE6E7281-4068-4E8A-867F-5D168F2178A5Q30979218-6B94CEC0-F01E-45E4-B7B8-374F0574CEA5Q31120792-B85CEFC1-C3B0-412A-8ACC-52A92A21FB8FQ33282917-1B34183C-A899-42D1-8AEE-26934B3D3B2CQ33301760-8A17E613-38E0-40AE-97D0-D2D75E066A0EQ33335930-7E878782-0908-45FD-8F0C-638559361A8DQ33389174-A62EEC17-2D7B-43EC-90D8-E097ADDC446AQ33442365-51595C00-94B7-4920-BB31-69EBCC769659Q33542800-FB8F99F5-6F58-404A-A78B-F6D2F91E08E9Q33637412-85AAB112-6BE8-45DF-A792-1E715E3FBFA9Q33659746-F0FEBB86-BDCC-44ED-A3DF-090A81DDC7CBQ33827840-30DADD40-5B30-45D9-BFBA-FE484BDEFE14Q33862295-A24FB434-F1EF-4FD0-8869-B1E470B175F1Q33876266-0C2E377B-E8E3-4558-A38E-A824DD54C63BQ33894276-3ECC2510-210A-4193-A529-2E7A8B2D88FCQ33911771-A1E7052C-BB43-4497-9E71-3B15EBB3A960Q33918017-9D49EEF3-919D-4217-87D5-DAAA3FCDEF9FQ34040461-86D43648-83FF-4BBF-A57F-27818179C0B5Q34211083-112327AB-1F9A-4892-B907-CDE9E33B51DFQ34272848-17BF1C19-D3F5-4D22-8918-9D1250837708
P2860
Recombinant activated factor VII for acute intracerebral hemorrhage.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant activated factor VII for acute intracerebral hemorrhage.
@ast
Recombinant activated factor VII for acute intracerebral hemorrhage.
@en
Recombinant activated factor VII for acute intracerebral hemorrhage.
@nl
type
label
Recombinant activated factor VII for acute intracerebral hemorrhage.
@ast
Recombinant activated factor VII for acute intracerebral hemorrhage.
@en
Recombinant activated factor VII for acute intracerebral hemorrhage.
@nl
prefLabel
Recombinant activated factor VII for acute intracerebral hemorrhage.
@ast
Recombinant activated factor VII for acute intracerebral hemorrhage.
@en
Recombinant activated factor VII for acute intracerebral hemorrhage.
@nl
P2093
P356
P1476
Recombinant activated factor VII for acute intracerebral hemorrhage
@en
P2093
Brett E Skolnick
Joseph Broderick
Kamilla Begtrup
Nikolai C Brun
Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators
Stephan A Mayer
Stephen Davis
Thorsten Steiner
P304
P356
10.1056/NEJMOA042991
P407
P577
2005-02-01T00:00:00Z